Royal Bank of Canada’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.49M | Buy |
558,061
+549,878
| +6,720% | +$9.35M | ﹤0.01% | 1873 |
|
|
2025
Q1 | $160K | Sell |
8,183
-2,035
| -20% | -$39.8K | ﹤0.01% | 4521 |
|
|
2024
Q4 | $253K | Buy |
10,218
+1,536
| +18% | +$38K | ﹤0.01% | 4170 |
|
|
2024
Q3 | $213K | Buy |
8,682
+68
| +0.8% | +$1.67K | ﹤0.01% | 4332 |
|
|
2024
Q2 | $202K | Buy |
8,614
+4,543
| +112% | +$107K | ﹤0.01% | 4381 |
|
|
2024
Q1 | $135K | Buy |
4,071
+2,135
| +110% | +$70.8K | ﹤0.01% | 4573 |
|
|
2023
Q4 | $53K | Sell |
1,936
-141
| -7% | -$3.86K | ﹤0.01% | 5424 |
|
|
2023
Q3 | $50K | Sell |
2,077
-21,260
| -91% | -$512K | ﹤0.01% | 5295 |
|
|
2023
Q2 | $746K | Buy |
23,337
+1,408
| +6% | +$45K | ﹤0.01% | 3242 |
|
|
2023
Q1 | $671K | Sell |
21,929
-3,262
| -13% | -$99.8K | ﹤0.01% | 3301 |
|
|
2022
Q4 | $985K | Buy |
25,191
+615
| +3% | +$24K | ﹤0.01% | 3104 |
|
|
2022
Q3 | $1.17M | Sell |
24,576
-6,901
| -22% | -$328K | ﹤0.01% | 2902 |
|
|
2022
Q2 | $1.22M | Buy |
31,477
+11,691
| +59% | +$453K | ﹤0.01% | 2937 |
|
|
2022
Q1 | $1.13M | Buy |
19,786
+13,650
| +222% | +$782K | ﹤0.01% | 3116 |
|
|
2021
Q4 | $489K | Buy |
6,136
+4,276
| +230% | +$341K | ﹤0.01% | 3979 |
|
|
2021
Q3 | $162K | Sell |
1,860
-2,848
| -60% | -$248K | ﹤0.01% | 4845 |
|
|
2021
Q2 | $605K | Buy |
4,708
+909
| +24% | +$117K | ﹤0.01% | 3673 |
|
|
2021
Q1 | $304K | Buy |
3,799
+2,292
| +152% | +$183K | ﹤0.01% | 4135 |
|
|
2020
Q4 | $123K | Buy |
1,507
+1,482
| +5,928% | +$121K | ﹤0.01% | 4669 |
|
|
2020
Q3 | $1K | Buy |
25
+4
| +19% | +$160 | ﹤0.01% | 5896 |
|
|
2020
Q2 | $1K | Sell |
21
-32
| -60% | -$1.52K | ﹤0.01% | 5903 |
|
|
2020
Q1 | $1K | Buy |
+53
| New | +$1K | ﹤0.01% | 5893 |
|